Cardiol Therapeutics Inc. (CRDL:NASDAQ) closed at $0.995 on November 6, 2026, up 7.39% on the day. The stock trades 57.5% below its 52-week high of $2.34 and 13.1% above its 52-week low of $0.880. Over the past year, it lost 5.2%. Cardiol Therapeutics Inc. is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, CRDL closed higher on 111 days (44%). Its best day was March 27, 2026 (+12.61%) and its worst was September 10, 2026 (-13.35%). The stock moved 10% or more in a single session 6 times.
Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, CVD. The CardiolRx is also being investigated in patients with acute myocarditis, a leading cause of cardiac death in people less than 35 years old.
Find more stocks like CRDL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.